Back to ACAD
Assenagon Asset Management S.A. → ACAD
Assenagon Asset Management S.A. ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
6
Latest value
$6.7M
Q3 2026
Peak value
$6.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $589K |
| Q4 2025 | $233K |
| Q1 2026 | $1.7M |
| Q2 2026 | $533K |
| Q2 2026 | $533K |
| Q3 2026 | $6.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $6.7M | 334.6K | — | — |
| Q2 2026 | $533K | 21.1K | — | — |
| Q2 2026 | $533K | 21.1K | — | — |
| Q1 2026 | $1.7M | 78.1K | — | — |
| Q4 2025 | $233K | 8.7K | — | — |
| Q3 2025 | $589K | 27.6K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M
$211.3M
$202.4M